The QualityStocks Daily Stock List
- Premier Oil plc (PMOIY)
- Argonaut Gold, Inc. (ARNGF)
- Item 9 Labs Corp. (INLB)
- PASSUR Aerospace, Inc. (PSSR)
- Altura Mining Limited (ALTAF)
- Dajin Resources Corp. (DJIFF)
- Maverick Technology Solutions (MVRK)
- Natural Health Farm Holdings, Inc. (NHEL)
- Escalon Medical Corp. (ESMC)
- Explor Resources, Inc. (EXSFF)
- Tiger Reef, Inc. (TGRR)
- Broadway Gold Mining Ltd. (BDWYF)
- Empire Petroleum Corp. (EMPR)
- Vycor Medical, Inc. (VYCO)
Premier Oil plc (PMOIY)
Zacks, YCharts, Morningstar, Marketbeat, Whale Wisdom, Street Insider, GuruFocus, Investing.com, Glassdoor, and Tech Know Bits reported beforehand on Premier Oil plc (PMOIY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
An oil and gas enterprise, Premier Oil plc engages in the exploration, production, and development of oil and gas properties. The Company does so mainly in the Falkland Islands, Indonesia, Pakistan, the United Kingdom (UK), Vietnam, and internationally. Its business strategy is to grow shareholder value through investing in high quality production and development opportunities. This is while maintaining exposure to upside value from successful exploration within a strict capital discipline framework. Premier Oil has its corporate office in London, England.
Premier has production spread across three regions, which diversifies risk. As at December 31, 2018, the Company had reserves and resources of approximately 867 mmboe. Premier had an Operating Cash Flow of US$777 million in 2018. It is working to maximize value from its low cost, stable production base to produce cash flows.
The Company’s exploration emphasis remains on under-explored but proven hydrocarbon basins. This includes the Sureste Basin, Offshore Mexico, and the North Sumatra Basin, Offshore Indonesia. In addition, Premier’s exploration emphasis includes adding high quality assets to its portfolio via selective acquisitions at low points in the commodity price cycles.
Premier’s 2019 production guidance is 75 kboepd, of which 70 percent is oil and 30 percent is gas. Regarding its strong producing asset base, Premier has manifold, high-value incremental projects across its producing portfolio. These include Catcher, Chim Sáo, Anoa, and Huntington. The Company is also optimizing future projects. These include BIG-P, Indonesia; Tolmount, UK; Sea Lion, Falkland Islands; as well as Zama, Mexico.
Pertaining to Exploration Upside, greater than 400 mmboe net unrisked potential resource could be added over the next two years. This includes Tolmount East, UK; Block 30, Mexico; Andaman II, Indonesia; and Block 717, Ceara Basin, Brazil. In 2018, project sanction was achieved for Tolmount, including a favorable funding structure. In 2018, Premier obtained highly prospective acreage in Mexico and Indonesia. In 2018, the Company had a Post Tax Profit of $133 Million after a previous year loss.
Premier Oil plc (PMOIY), closed Thursday's trading session at $1.1099, up 17.45%, on 3,300 volume with 5 trades. The average volume for the last 3 months is 4,640 and the stock's 52-week low/high is $0.689/$1.95.
Argonaut Gold, Inc. (ARNGF)
The Northern Miner, Stock Guru, StocksBeat, TipRanks, Mining Stock Valuator, Marketbeat, StockScores, Canadian Mining Journal, Invest Tribune, Wallmine, and StockInvest reported previously on Argonaut Gold, Inc. (ARNGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Argonaut Gold, Inc. engages in exploration, mine development, and production activities in North America. It mainly explores for gold and silver deposits. The Company’s chief assets include the El Castillo mine situated in the State of Durango, Mexico; and the San Agustin project situated in the State of Durango, Mexico. This year, Argonaut Gold plans to invest $50 to $60 million in capital expenditures. Listed on the OTC Markets, Argonaut Gold is based in Reno, Nevada.
Together, the El Castillo mine and the San Agustin project form the El Castillo Complex in Durango, Mexico, and the La Colorada mine in Sonora, Mexico. In addition, the Company’s advanced exploration projects include the San Antonio project in Baja California Sur, Mexico; the Cerro del Gallo project in Guanajuato, Mexico; and the Magino project in the Province of Ontario, Canada. Furthermore, Argonaut Gold has a number of exploration stage projects, all of which are situated in North America.
This year, Argonaut Gold expects to produce greater than 200,000 GEOs (gold equivalent ounces) annually from its existing operations. This would reflect more than 65 percent production growth from 2017 through 2019. This production growth is principally driven by the ramp up of the El Castillo Complex with the addition of San Agustin and the extension of mine life at El Castillo subsequent to the San Juan concession purchase from Fresnillo Plc, and also higher anticipated grades at La Colorada as mining transitions to the El Creston pit.
Pertaining to 2019 Guidance, Argonaut Gold anticipates it will produce between 200,000 to 215,000 GEOs during 2019 at a cash cost of between $775 to $875 per gold ounce sold and all-in sustaining costs (AISC) of between $975 to $1,075 per gold ounce sold.
Recently, Argonaut Gold announced its operating and financial results for Q1 ended March 31, 2019. The Company reported record Quarterly Production of 54,169 gold equivalent ounces (GEO or GEOs), a quarterly Net Cash increase of $11.7 million, Cash Flow From Operating Activities Before Changes In Operating Working Capital of $18.0 million, Net Income of $4.1 million or Earnings Per Share of $0.02, and Adjusted Net Income of $2.4 million or Adjusted Earnings Per Share of $0.01.
Argonaut Gold, Inc. (ARNGF), closed Thursday's trading session at $1.431, up 10.08%, on 34,068 volume with 41 trades. The average volume for the last 3 months is 16,746 and the stock's 52-week low/high is $0.85/$1.86.
Item 9 Labs Corp. (INLB)
CannabisMarketCap, Street Signals, Stocks Beat, Street Insider, Pot Stock News, Nasdaq, OTC Markets, and TipRanks reported previously on Item 9 Labs Corp. (INLB), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Item 9 Labs Corp. is a leader in comfortable cannabis health solutions for the modern consumer. The Company’s asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. It is also advancing the industry with its product suites. The Company has created complementary brands - Item 9 Labs and Strive Wellness - to channel consumer diversity. Item 9 Labs has its corporate office in Phoenix, Arizona. It has medical cannabis operations in numerous United States markets.
Item 9 Labs is bringing best of industry practices to markets from coast to coast. This is via cultivation and production, distinctive retail environments, licensing services, and varied product suites catering to different medical cannabis demographics. The Company’s Dispensary Permits is its consulting firm. It specializes in strategic license application and compliance. The Dispensary Templates subdivision of Item 9 Labs is a technology platform with a wide-ranging digital library of licensing and business planning resources. Strive Life is a turnkey dispensary model for the retail sector. It enhances the patient experience with consistent and first-rate service, high-end design, and precision-tested products. At present, Strive Life is undergoing implementation in Arizona and North Dakota.
Item 9 Labs’ propriety delivery platforms include the Apollo Vape and Pod system, and a leading-edge intra-nasal device. The Company has received many praises for its medical-grade flower and concentrates. Item 9 Labs’ intention is to manage cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets by the end of this year. Present facilities include distribution and processing operations Strive Wellness of Ohio and Strive Wellness of Nevada, and also dispensary Strive Life North Dakota.
Medical marijuana dispensary Strive Life Grand Forks, a partner following the Company’s Strive Life business model and brand, officially opened on Wednesday, May 22, 2019, at 1809 13th Avenue North, in Grand Forks, North Dakota. The operation offers a varied inventory of patient-focused products. Strive Life Grand Forks implements medical marijuana dispensary best practices from across the U.S. and internationally.
Item 9 Labs announced its expanded Arizona cultivation and manufacturing facility received State approval to operate. The custom 10,000 square-foot construction passed inspections on June 4, 2019. It commenced production the week of June 10, 2019. The new building features technology improvements in all areas of the grow process. This includes advanced irrigation, lighting, HVAC, as well as upgraded environmental controls.
Item 9 Labs Corp. (INLB), closed Thursday's trading session at $3.00, even for the day, on 200 volume with 2 trades. The average volume for the last 3 months is 4,928 and the stock's 52-week low/high is $1.50/$8.39.
PASSUR Aerospace, Inc. (PSSR)
Zacks, Journal Transcript, Investors Hangout, OTC Markets, Stockwatch, Trading View, Marketbeat, The Street, Stockhouse, Wallet Investor, Market Screener, and Simply Wall St reported earlier on PASSUR Aerospace, Inc. (PSSR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
PASSUR Aerospace, Inc.’s mission is to improve worldwide air traffic efficiencies through connecting the world’s aviation professionals onto a single aviation intelligence platform. The Company is an international leader in digital aviation operational excellence. PASSUR provides predictive analytics and decision support technology for the aviation industry, primarily to improve the operational performance and cash flow of airlines and the airports where they operate. Established in 1967, PASSUR Aerospace is based in Stamford, Connecticut.
PASSUR’s information solutions are used at the five largest North American airlines, by more than 60 airport customers, and used at the top 30 North American airports, by over 100 business aviation customers, and by the U.S. government. The Company owns and operates the largest commercial passive radar network globally. It provides aircraft position updates every 1 to 4.6 seconds, powering a proprietary database that is accessible in real-time, and delivers timely and accurate information and solutions through PASSUR’s industry leading algorithms and business logic included in its products.
In addition, 53 percent of all U.S. domestic commercial flights are managed with PASSUR predictive analytics for predicted arrival times, by using years of archived data, and real-time airspace analysis. This enables airlines and airports to always be ready for the aircraft.
The Company maximizes airspace, runways, and gate usage, through using predictive analytics to determine how airports should be configured to get the most out of their capacity. PASSUR helps airlines, airports, and air traffic control prioritize departures to maximize capacity and minimize delays, by helping to ensure that all three stakeholders work together with the most accurate, timely information.
Recently, PASSUR® Aerospace announced the latest version of its flagship flight trajectory technology, a solution designed to optimize airline and airport systems and processes that depend on accurate trajectories. The Company’s trajectory solutions are now deployed in the United States, Canada, Mexico, and Western Europe.
PASSUR'S flight trajectory prediction solutions are also a significant element in other PASSUR solutions, including Hold and Diversion Management, Airport Capacity Management, Surface Optimization, and Departure and Arrival Sequencing. The Company’s platform provides digital decision-support to predict, prevent, as well as operational resilience and recovery.
This week, PASSUR® Aerospace announced Revenues of $3,634,000 for the three months ended April 30, 2019, versus $3,502,000 for the same period in fiscal year 2018. This represents an increase of $132,000, or 4 percent. For the six months ended April 30, 2019, Revenues totaled $7,290,000, versus $7,015,000 for the same period in fiscal year 2018. This represents an increase of $275,000, or 4 percent. PASSUR Aerospace will host its quarterly conference call on Tuesday, June 25, 2019, at 4:30 p.m. EDT.
PASSUR Aerospace, Inc. (PSSR), closed Thursday's trading session at $1.2345, even for the day, on 166 volume. The average volume for the last 3 months is 671 and the stock's 52-week low/high is $1.049/$1.73.
Altura Mining Limited (ALTAF)
TipRanks, OilandGas360, HotCopper, Wallmine, YCharts, Invest Tribune, Investing News, Insider Financial, Stock Invest, and Micro Small Cap reported earlier on Altura Mining Limited (ALTAF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Altura Mining Limited engages in the exploration and development of mineral properties in Australia and Indonesia. The Company operates via Coal Mining, Lithium Mining, Exploration Services, and Mineral Exploration segments. In addition, Altura provides drilling services to mining and exploration companies. Altura Mining is based in Perth, Australia.
Altura is an important player in the worldwide lithium market and is taking advantage of growing demand for raw materials for manufacturing lithium ion batteries for electric vehicles (EVs) and static storage uses. The Company is concentrating on the construction and development of its 100 percent owned Pilgangoora Lithium project positioned in the Pilbara region of Western Australia. The Pilgangoora Project is a producing lithium operation.
Altura's mine at Pilgangoora produced first lithium in July of 2018. First sales were in October of 2018, and commercial production was declared in March of this year. The project, at Pilgangoora in Western Australia, is roughly a 123 km drive from the town of Port Hedland. The Pilgangoora Mining Lease tenements, encompassing the resource modelling area, are M45/1230 and M45/1231 and cover an area of 394 hectares.
The mining operation at Pilgangoora consists of an open pit mine, processing plant and support infrastructure. At full production the mine will produce roughly 220,000 tonnes of lithium spodumene concentrate per annum.
The life of mine is forecast to be 26 years at present rates. However, at the request of Altura Mining’s offtake partners, the Company has completed a definitive feasibility study for expansion study of the project. This proposed Stage 2 expansion will result in mine output increasing to 450,000 tonnes annually. Start of Stage 2 is subject to Altura Mining entering long term offtake agreements with customers, securing funding for the expansion, and also final Board approval.
For May 2019, Altura Mining had record monthly production of 15,737 wmt, representing 86 percent of planned nameplate capacity. The current quarter has delivered strong sales with 24,881 dmt of product shipped, with a further minimum 13,000 dmt scheduled this month. Recent production numbers have demonstrated a considerable improvement in the performance of the process plant that has seen the project attain multiple daily record production levels at or above the nameplate capacity.
Altura Mining Limited (ALTAF), closed Thursday's trading session at $0.072, up 10.77%, on 627,211 volume with 9 trades. The average volume for the last 3 months is 51,053 and the stock's 52-week low/high is $0.0609/$0.28.
Dajin Resources Corp. (DJIFF)
StreetWise Reports, Penny Stock Tweets, GoldTelegraph, The Prospector News, 24hgold, Metals News, Investing News, Junior Mining Network, BullMarketNews, 4-Traders, Mining Feeds, StockInvest, Simply Wall St, and OTC Markets reported earlier on Dajin Resources Corp. (DJIFF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Dajin Resources Corp., together with its subsidiaries, mainly engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Argentina. An early stage Lithium brine exploration company, Dajin, via its interest in Dajin Resources S.A. (Dajin S.A.), holds concessions or concession applications in Jujuy Province, Argentina, which were acquired in areas known to contain brines with Lithium, Potassium and Boron values. Dajin Resources has its corporate headquarters in Vancouver, British Columbia.
The land holdings in Jujuy Province, Argentina exceed 93,000 hectares (230,000 acres). They are chiefly situated in the Salinas Grandes and Guayatayoc salt lake basins. Dajin S.A. is partnered with Pluspetrol Resources Corporation B.V. - as operator is required to spend $2,000,000 to earn a 51 percent interest in Dajin S.A. Lithium properties.
The Phase One exploration program of the 4,400 hectares (10,873 acres) in San Jose-Navidad minas has completed the program where 25 shallow brine samples were taken. The assays returned Lithium brine concentrations ranging from 281 mg/l to 1,353 mg/l averaging 591 mg/l.
In addition, Dajin holds a 100 percent interest in 403 placer claims encompassing 7,914 acres (3,202 hectares) in the Teels Marsh valley of Mineral County, Nevada. These claims are known to contain Lithium and Boron values. They are next to the birth place of US Borax Corp's first borax mine.
Furthermore, Dajin holds a 100 percent interest in 145 placer claims encompassing 2,921 acres (1,182 hectares) in the Alkali Spring valley (also called Alkali Lake valley) of Esmeralda County, Nevada, positioned 7 miles (11 kilometers) northeast of Albemarle's Silver Peak Lithium brine operation in Clayton Valley.
In November of 2018, Dajin Resources announced the signing of a Definitive Agreement with Cypress Development Corp. (TSX-V: CYP) (OTCQB: CYDVF) for the exploration and development of Dajin Resources’ Alkali Spring valley Lithium property in Esmeralda County, Nevada. This property is 12 kilometers (7.5 miles) northeast of Cypress Development’s Clayton Valley Lithium project in Nevada. With this Agreement, Cypress will have the exclusive right and option to acquire a 50 percent undivided interest in Dajin Resources’ unpatented placer mining claims and application for water rights in Alkali Spring valley, Esmeralda County.
Recently, Dajin Resources reported that Pluspetrol Resources Corporation B.V. acquired 100 percent of the issued and outstanding common shares of LSC Lithium Corporation (LSC) for a cash consideration of about CDN $111 million. Dajin was partnered with LSC who has, by way of its wholly-owned subsidiary Lithium S Holding Corporation, an earn-in agreement to spend CDN $2,000,000 to earn a 51 percent interest in Dajin Resources S.A. Pluspetrol has created the company Litica Resources S.A. for exploration and development of its concessions.
Dajin Resources Corp. (DJIFF), closed Thursday's trading session at $0.029, off by 10.77%, on 52,500 volume with 5 trades. The average volume for the last 3 months is 53,056 and the stock's 52-week low/high is $0.025/$0.091.
Maverick Technology Solutions (MVRK)
OTC Markets, Penny Stock Hub, Biz Journals, News to Watch, OTC.Watch, Research Pool, Investors Hangout, Stockopedia, Stockhouse, Trading View, Wallet Investor, GlobeNewswire and InvestorsHub reported earlier on Maverick Technology Solutions (MVRK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Maverick Technology Solutions is the manufacturer of the highly acclaimed ROSINBOMB™ line of extraction presses and technology. The Company has more than three years operating history developing and producing the ROSINBOMB™ line of rosin presses and accessories for extracting organic concentrates. ROSINBOMB presses necessitate no chemicals or additional hardware to operate. Maverick Technology Solutions is headquartered in Phoenix, Arizona. Maverick lists on the OTC Markets.
The Company established as a family enterprise with deep roots in creating press technology for the organic fruit and vegetable juice market. ROSINBOMB presses are plug and play out of the box. The technology utilizes granted patent and patent pending techniques to optimize extraction processes and permit the user the ability to easily produce naturally-extracted, organic concentrates.
ROSINBOMB presses are manufactured to be the premier quality presses available today. The Company’s stainless steel, fully electric and patent-pending technology delivers 5,000+ lbs of pressure. The design is to ensure the highest possible yield.
This past February, Maverick Technology Solutions announced that its patent pending products are now available through Walmart. The entire product line is prominently featured on Walmart.com. Maverick’s extraction presses and related accessories, most notably the ROSINBOMB Rocket, have been met with critical acclaim. The year 2018 saw the Rocket being named a top ten product by Forbes, the “Best Portable Rosin Press” by Herb, and one of the “Top Holiday Gifts Over $200” by Leafly.
Recently, Maverick Technology Solutions announced the naming of Mr. Douglas Leighton as Chairman of its Advisory Board. Mr. Leighton is Founder and Principal Partner of Altar Rock Capital, (previously Dutchess Capital). He has managed an investment portfolio of more than $2 billion in transactional value. Mr. Leighton was appointed to the Maverick Technology Solutions Advisory Board as Chairmen to help guide the company through the next chapter of its growth and success.
Maverick Technology Solutions (MVRK), closed Thursday's trading session at $1.21, up 21.00%, on 6,000 volume with 11 trades. The average volume for the last 3 months is 1,657 and the stock's 52-week low/high is $0.056/$2.09.
Natural Health Farm Holdings, Inc. (NHEL)
4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Stockopedia, Stockhouse, Market Exclusive, last10k, Barchart, and CapitalCube reported previously on Natural Health Farm Holdings, Inc. (NHEL), and today we chose to report on the Company, here at the QualityStocks Daily Newsletter.
Natural Health Farm Holdings, Inc. is a biotechnology company working to form a complete healthcare one-stop shop based on natural or naturopathic products. Since November 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of different diseases and nutritional consulting services. Natural Health Farm Holdings is based in Las Vegas, Nevada.
The Company provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. Natural Health Farm’s chief activities are in retailing nutritional supplements, organic foods and health-care related products.
Through its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of manifold retail & franchise outlets located throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.
Earlier this month, Natural Health Farm Holdings, announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With this agreement, Natural Health Farm Holdings shall acquire 100 percent of Natural Tech R&D’s outstanding shares for USD 1 Million.
Last week, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements enterprise in Malaysia.
With this agreement, Natural Health Farm Holdings shall acquire 100 percent of Excel Herbal Industries’ outstanding shares for USD 2 Million. The anticipation is that Natural Health Farm Holdings shall complete the due diligence process and close the transaction within 60 calendar days from the term sheet date.
Natural Health Farm Holdings, Inc. (NHEL), closed Thursday's trading session at $0.11, up 37.50%, on 25,000 volume with 3 trades. The average volume for the last 3 months is 132,653 and the stock's 52-week low/high is $0.0719/$6.00.
Escalon Medical Corp. (ESMC)
Stock Twits, Dividend Investor, Zacks, Morningstar, Market Screener, Simply Wall St, Wallet Investor, OTC Picks, MarketWatch, last10k, GuruFocus, Capital Cube, Stockhouse, last10k, Equity Clock, Wall Street Resources, FeedBlitz, PennyToBuck, 4-Traders, InvestorsHub, and YCharts reported previously on Escalon Medical Corp. (ESMC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Escalon Medical Corp. specializes in the development, marketing, and distribution of ophthalmic diagnostic imaging and surgical products. It is working to grow its ophthalmic business through concentrating on its existing products, developing new products, utilizing strategic partnerships, and through acquisition.
Escalon Medical has its corporate headquarters in Wayne, Pennsylvania. The Company also has operations in Lake Success, New York; New Berlin, Wisconsin, and Stoneham, Massachusetts. Escalon Medical’s shares trade on the OTC Markets Group’s OTCQB.
Escalon Medical primarily markets to teaching institutions, hospitals, and eye surgery centers. The Company acquired Sonomed, Inc. in 2000. Since then, by way of acquisition, product divestitures, partnerships, and product development, it has grown and expanded its product offerings. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.
Escalon Medical’s products include an assortment of ophthalmic ultrasound, digital imaging and photography, and image management systems. In addition, its products include surgical products, including intraocular gases, fiber optic light guides and sources, and other surgical vitreoretinal instruments.
All of the Company’s ophthalmic products are branded as Sonomed Escalon. Furthermore, Sonomed Escalon maintains certification for compliance with ISO1385 Quality Management Systems for Medical Devices.
Sonomed Escalon provides ultrasound, digital photography, and image management systems. Sonomed Escalon Rx products include mydriatics/cyclopegics; diagnostic supplies; anesthetics/combo products; antibiotics, steroid combination; injectable dyes, surgical products, and office products.
Concerning tonometry, Sonomed Escalon has its “diatom IOP measuring device.” This involves measuring IOP through the eyelid on sclera with no corneal contact. It rapidly provides accurate IOP reading independent of corneal thickness. Additionally, it is ideal for cases where standard tonometry cannot be used. No anesthesia is required and there is no need to remove contact lenses, no need for sterilization, and no patient discomfort or anxiety.
Moreover, surgical solutions offered include vitreoretinal gases and devices. Its diagnostic solutions include AXIS image management; ophthalmic ultrasound; mobile vision analysis; adaptive refractor; perimetry; digital imaging, and tonometry.
Sonomed Escalon offers its Vu Pad pertaining to Ophthalmic Ultrasound. This is a new class of ophthalmic ultrasound versatility. Vu Pad is configurable with B-scan, A-scan, UBM or any combination.
Escalon Medical established in 1987. The Company sells its products to medical institutions by way of independent sales representatives, a network of distributors, and internal sales employees.
Escalon Medical Corp. (ESMC), closed Thursday's trading session at $0.134, up 48.89%, on 400 volume with 2 trades. The average volume for the last 3 months is 4,564 and the stock's 52-week low/high is $0.0821/$0.36.
Explor Resources, Inc. (EXSFF)
Streetwise Reports, Vantage Wire, Stockhouse, and InvestorsHub reported earlier on Explor Resources, Inc. (EXSFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Explor Resources, Inc. is a natural resources company headquartered in Rouyn-Noranda, Quebec. The Company has mineral holdings in Ontario, Quebec, Saskatchewan and New Brunswick. Its Flagship project is the Timmins Porcupine West (TPW) Project situated in the Porcupine mining camp in Ontario. A gold and base metals exploration company, Explor Resources lists on the OTC Markets Group’s OTCQB.
The Company is presently concentrating on exploration in the Abitibi Greenstone Belt. This belt is in both provinces of Ontario and Quebec - roughly 33 percent in Ontario and 67 percent in Quebec. Explor’s total land position in the Abitibi Greenstone Belt is about 25,000 hectares. In addition, Explor owns 6,500 hectares of mining claims in New Brunswick.
Abitibi Greenstone Belt properties 100 percent-owned by the Company in Ontario include Carnegie, Kidd Township, Eastford Lake, PG-101, Montrose, Golden Harker, Timmins Porcupine West, and Ogden. Abitibi Greenstone Belt properties 100 percent-owned by Explor Resources in Quebec include East Bay, Nelligan, Destor, and Launay.
Explor Resources has signed a Memorandum of Understanding (MOU) with the Matachewan First Nation of Matachewan, Ontario and the Mattagami First Nation of Gogama, Ontario, concerning the Montrose Property. The MOU will serve as a structure to govern the relationship between Explor Resources and the First Nations in accordance with their intention of further building a relationship characterized by cooperation and mutual respect, in connection with the development of the Montrose Property.
The Montrose property consists of 20 mining claims (217 units) positioned in the Montrose and Midlothian Townships in the Timmins-Porcupine Mining Camp for a total of around 3,472 hectares.
In December 2017, Explor Resources announced the acquisition of two mining claims (3 units) located in Ogden Township, in the Porcupine Mining Division, District of Cochrane, Ontario for a total of 48.56 hectares. The claims are in Ogden Township contiguous and to the east of the Timmins Porcupine West Gold Property.
The claims were acquired because of encouraging results obtained in the Company's past exploration on the property. Explor Resources will pay CDN $2,000 and issue 100,000 common shares to obtain a 100 percent interest in the additional Ogden mining claims. The Optionors have retained a 2 percent NSR (Net Smelter Return) in the property.
Last month, Explor Resources announced the results of the East Bay Gold Property exploration program. The analysis of earlier exploration by Cambior and the results of the previous exploration program completed by Explor Resources confirmed a number of interesting drill targets. The exploration program comprised a Phase III 3000 meter drill program.
The East Bay Gold Property is positioned to the west of the Consolidated Beattie and Donchester Gold Property. It is contiguous to the ground on which the former Clifton Star Resources, Inc. intersected wide width of gold mineralization.
Furthermore, Explor Resources announced recently the acquisition of eight mining claims (64 claim units) located in Hoyle Township, in the Porcupine Mining Division, District of Cochrane, Ontario for a total of 1036.4 hectares. The claims are positioned in Hoyle Township, north of Bell Creek, Owl Creek and Hoyle Pond gold Mines.
The claims were obtained because of results attained by Tahoe Resources and Goldcorp in their exploration programs in Hoyle Township. Explor Resources will pay CDN $1,000 and issue 3,000,000 common shares to obtain a 100 percent interest in the property.
Explor Resources, Inc. (EXSFF), closed Thursday's trading session at $0.022, up 37.50%, on 219,581 volume with 14 trades. The average volume for the last 3 months is 16,985 and the stock's 52-week low/high is $0.00669/$0.035.
Tiger Reef, Inc. (TGRR)
Investors Hub and MarketWatch reported on Tiger Reef, Inc. (TGRR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Tiger Reef, Inc. is a diversified producer of ultra premium rums under the Tiger Reef® brand. Also, the Company is a developer of casual dining restaurant properties in the Caribbean under the Mermaid Reef Ocean Grill & Lounge™ brand. The Company formerly went by the name Blue Water Bar & Grill, Inc. It changed its corporate name to Tiger Reef, Inc. in October 2016.
The Company is a subsidiary of BWG Investments & Development, Ltd. Tiger Reef’s shares trade on the OTC Markets’ OTCQB. Tiger Reef is based in Cole Bay, the Netherlands Antilles.
Tiger Reef has established a new wholly-owned operating subsidiary in St. Maarten, Dutch West Indies under the name Mermaid Reef, B.V. Mermaid Reef will own and operate the initial Mermaid Reef Ocean Grill & Lounge™ in St. Maarten.
In May 2017, Tiger Reef announced that its wholly-owned subsidiary, Tiger Reef Spirits, Ltd., entered into a Letter of Intent (LOI) with International Spirits & Beverage Group, Inc. (ISBG). ISBG is a Nevada based alcoholic beverage company. It specializes in the development, marketing, and global sales of innovative wine and spirits brands.
ISBG will assist Tiger Reef with obtaining U.S. regulatory approval for the complete line of Tiger Reef® ultra premium rums. In addition, ISBG will become the U.S. importer of record for Tiger Reef’s complete line of rums.
The Mermaid Reef Ocean Grill & Lounge™ was being developed at Simpson Bay Resort & Marina on the island of St. Maarten, Dutch West Indies. Key elements of the Restaurant floor plan included the restaurant encompassing 2,466 sq. ft. of indoor and outdoor waterfront space.
In October of 2017, Tiger Reef issued its first statement and shareholder update since the Company’s St. Maarten headquarters experienced a direct hit from Hurricane Irma during the early morning hours on September 6, 2017. Tiger Reef’s office headquarters suffered catastrophic damage during the Hurricane Irma storm.
All of the Company’s office equipment, computers, paper files, and more were damaged beyond repair during the storm. However, electronic files were backed up offsite and were recovered. Tiger Reef was renovating a leased waterfront restaurant space in the Simpson Bay Resort & Marina in preparation of opening the first Mermaid Reef Ocean Grill & Lounge™ in time for the 2017 tourist season. In addition, Simpson Bay Resort & Marina and the Company’s restaurant location suffered massive damage and flooding.
Tiger Reef and Simpson Bay Resorts & Marina Management had numerous discussions since the storm concerning the future of the resort and restaurant. Based on the fact that the resort would be closed for a minimum of six months, but probably longer, and other uncertainties, Tiger Reef and Simpson Bay Resorts & Marina mutually agreed to terminate the lease agreement for the restaurant space. Tiger Reef will make a one-time write-off or its lost investment in this restaurant property.
Tiger Reef temporarily suspended all efforts related to the Mermaid Reef Ocean Grill & Lounge™ brand. The Company said this past October that it would re-evaluate its options for the brand in the coming months after it recovers from the losses incurred due to Hurricane Irma.
Tiger Reef, Inc. (TGRR), closed Thursday's trading session at $0.0022, up 29.41%, on 24,274,755 volume with 81 trades. The average volume for the last 3 months is 830,375 and the stock's 52-week low/high is $0.00089/$0.006.
Broadway Gold Mining Ltd. (BDWYF)
Streetwise Reports, Stockhouse, Barchart, and InvestorsHub reported on Broadway Gold Mining Ltd. (BDWYF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
A resource company, Broadway Gold Mining Ltd. centers on development-stage projects with advanced exploration potential. The Company owns a 100 percent interest in the Madison copper-gold project in the Butte-Anaconda mining region of Montana. Broadway Gold Mining’s shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate office in Vancouver, British Columbia.
The Madison copper-gold project is permitted for exploration. It contains a past-producing underground mine that Broadway Gold Mining has refurbished. The Company is expanding known copper and gold zones, which remain open for development in the mine's perimeter.
Broadway’s exploration program has identified new anomalies across its wide-ranging land package. These provide drill targets believed to be associated with large-scale porphyry mineralization.
The Company identified copper-gold porphyry targets at Madison in 2017, supported by a newly assembled geological model. Phase I and II drilling this year returned high-grade gold and copper intersections from shallower skarn zones. Many high-priority targets, including porphyry, will be the emphasis of Phase III drilling.
In October, Broadway Gold Mining announced the discovery of a new latite porphyry zone of mineralization at its Madison project in the legendary Butte-Anaconda mining region of Montana.
Mr. Duane Parnham, Broadway Gold Mining’s President and Chief Executive Officer, said, "Broadway's technical team has successfully delivered on a fourth major milestone worthy of additional testing by discovering a porphyry system underlying the shallower skarn zones, which were mined in the past and expanded in our recent drilling. Although indications suggest a typical copper porphyry alteration system is present, this new mineralization discovered at Madison exhibits similar characteristics to the latite porphyry hosted at Barrick's Golden Sunlight Mine (GSM) located 36 kilometers away in Whitehall, Montana."
Last month, Broadway Gold Mining announced that, as a result of its recent porphyry discovery, it has staked additional ground to cover favorable geological and geophysical targets in the area of its 100 percent-owned Madison copper-gold project.
The new claims are contiguous to the south of the Company’s active exploration area. The new claims extend the current Madison property footprint to 2,514 acres.
Broadway’s Phase III drilling program continues. The Company is fully funded for completion of the program. Deeper geophysical targets from the 2017 survey appear to trend through the original property boundary onto the newly acquired claims.
Broadway Gold Mining Ltd. (BDWYF), closed Thursday's trading session at $0.0708, up 29.07%, on 76,100 volume with 4 trades. The average volume for the last 3 months is 4,981 and the stock's 52-week low/high is $0.0209/$0.14579.
Empire Petroleum Corp. (EMPR)
Nebula Stocks, OTC Markets, and The Street reported previously on Empire Petroleum Corp. (EMPR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Empire Petroleum Corp. engages in the exploration and development of oil and gas interests in North America. The Company owns interest in the Gabbs Valley prospect and interest in the South Okie prospect. The Gabbs Valley prospect is an area of roughly 34,186 gross acres in Nye and Mineral Counties, Nevada. The South Okie prospect encompasses 110 net acres of oil and gas leases in Natrona County, Wyoming. Established in 1983, Empire Petroleum has its corporate headquarters in Tulsa, Oklahoma.
The Company has conducted comprehensive geological studies, conducted a seismic survey, carried out a geochemical imaging survey, conducted satellite and gravity studies and drilled two test wells on the Gabbs Valley Prospect. The additional studies of such data and the assistance of geological and engineering consultants led Empire Petroleum to conclude that additional drilling was warranted. The determination was that a new test well should be drilled employing a different method of drilling.
Empire Petroleum drilled the Paradise Unit 2-12 well to a depth of 4,250 feet before drilling problems caused them to stop drilling. The Company assigned the lease and the 1-12 and 2-12 wells to the other leasehold owners from which Empire had taken a farmout. Empire Petroleum does feel the prospect has considerable geological merit since the main target, being the Triassic formation, was not reached in either of the two test wells.
Empire Petroleum and Sierra Nevada Oil, LLC concentrated their activities on the exploration and development of approximately 36,750 acres of Bureau of Land Management (BLM) leases positioned on a surface anticline in Gabbs, Nevada. Three exploratory wells were drilled on the leases.
In December 2016, Empire Petroleum announced that it entered into an Agreement (Contribution Agreement) with Masterson West, LLC, concerning a newly-formed entity, Masterson West II, LLC (MWII). Upon closing, Empire Petroleum will own up to a maximum of 50 percent of MWII if it delivers $18,000,000 with a proportionate decrease down to 25 percent of Masterson West II at the lower end of the range.
The oil and gas properties are in Moore and Potter Counties in the Texas Panhandle. The wells to be included in the transaction primarily target the Red Cave formation.
In September 2017, Empire Petroleum announced that it entered into a term sheet to acquire producing oil and gas assets in North Louisiana. The oil and gas properties are the East Haynesville and Oaks Fields in Claiborne Parish, Louisiana. The wells to be included in the transaction target the Pettit, Lower and Upper Haynesville, Cotton Valley and Smackover reservoirs.
Recently, Empire Petroleum announced that its Board of Directors retained Pritchard Griffin Advisors (PGA) to advise Empire on its potential NW Louisiana transaction and on other prospective mergers, joint ventures (JVs), and acquisitions for the Company.
Mr. Mike Morrisett, President of Empire Petroleum Corporation, said, “We are very pleased to have PGA engaged with the Company. Their breadth of experience, knowledge, and contacts in most of the major oil and gas basins in the U.S., specifically within the East Texas/Louisiana Cotton Valley/Haynesville play, provides the Company with the confidence to implement our initial strategy within this region.”
Empire Petroleum Corp. (EMPR), closed Thursday's trading session at $0.28, up 33.33%, on 52,000 volume with 2 trades. The average volume for the last 3 months is 7,670 and the stock's 52-week low/high is $0.10/$0.75.
Vycor Medical, Inc. (VYCO)
PennyStockScholar, FeedBlitz, OTCtipReporter, and Wall Street Resources reported earlier on Vycor Medical, Inc. (VYCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Vycor Medical, Inc. is a provider of distinct and first-class surgical and therapeutic solutions. The Company operates two business units - Vycor Medical and NovaVision. Both of these business units adopt a minimally or non-invasive approach. Vycor Medical has U.S. Food and Drug Administration (FDA) 510(k) clearance for brain and spine surgeries and regulatory approvals for brain in Australia, Brazil, Canada, China, Europe (EU – Class III), Korea, Japan, Russia, and Taiwan. Vycor Medical is based in Boca Raton, Florida.
The Company’s NovaVision provides non-invasive, computer-based rehabilitation targeted at a substantial and largely un-addressed market of people who have lost their sight because of stroke or brain injury. The NovaVision business unit develops and provides science-driven neurostimulation therapy and other medical technologies. This helps improve and partially restore sight in patients with neurological vision impairments.
Vycor Medical’s ViewSite™ Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices. These have the potential for quicker, safer, and also more economical brain surgeries, as well as faster patient discharge.
The design of VBAS is to optimize neurosurgical site access and reduce patient risk. In addition, the design of VBAS is to expedite recovery and add tangible value to the professional medical community.
The Company’s proprietary Visual Restoration Therapy® (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury (TBI), or other acquired brain injuries. VRT is the only FDA 510K cleared medical device in the United States targeted at the restoration of vision for neurologically induced vision loss.
Vycor Medical has developed NeuroEyeCoach™. This is a therapy that is highly complementary to VRT™. NeuroEyeCoach™ is a compensation therapy registered in the United States as a Class I 510(k) exempt device. The design of NeuroEyeCoach is to improve a patient's ability to scan their environment more efficiently. NeuroEyeCoach is NovaVision's eye movement compensation therapy for patients who have suffered a cerebral visual field disorder due to a stroke or brain injury.
In August, Vycor Medical reported financial results for the three and six months ended June 30, 2017. The Company’s Revenues for the six months ended June 30, 2017 were $736,000 versus $779,000 for the same period the year prior. Cash Operating Loss was $235,000, versus $329,000 for the same period in 2016. This represents a reduction of 29 percent. Operating Loss was $654,000, versus $806,000. This represents a reduction of 19 percent.
During the period, the US patent office (USPTO) issued/allowed four patents. These are all directed to the integration of neuro-navigation systems with Vycor Medical's VBAS retractor system.
The patents complement and strengthen the Company’s existing patent portfolio. This is especially in relation to Vycor’s continuing emphasis to more fully integrate its VBAS product range with neuro-navigation systems without sacrificing the surgeon's ability to visually inspect the surrounding tissue as the devices undergo insertion.
Vycor Medical, Inc. (VYCO), closed Thursday's trading session at $0.17, up 106.56%, on 16,066 volume with 7 trades. The average volume for the last 3 months is 1,928 and the stock's 52-week low/high is $0.0321/$0.35.
The QualityStocks Company Corner
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- Net Element, Inc. (NASDAQ: NETE)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Green Hygienics Holdings Inc. (GRYN)
- Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
- VPR Brands, LP (VPRB)
- SinglePoint, Inc. (SING)
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
- Youngevity International, Inc. (NASDAQ: YGYI)
- INmune Bio Inc. (NASDAQ: INMB)
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that it has now shipped its first cannabis products to the province of Quebec, following purchase orders placed with the Société québécoise du cannabis (SQDC) and following registration with the Autorité des Marchés Publics. Also today, the company was highlighted in a “potcast” from Investorideas.com, examining the SQDC deal in greater detail.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $6.39, up 2.24%, on 701,505 volume with 2,522 trades. The average volume for the last 3 months is 1,029,171 and the stock's 52-week low/high is $2.97/$8.439.
- Organigram sends first shipment to Quebec; Organigram products now available in all ten provinces
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move June 20th
- 420 with CNW – Poll Shows Americans want CBD as an OTC Drug
Net Element (NASDAQ: NETE)
Net Element, Inc. (NASDAQ: NETE) ("Net Element" or the "Company"), a global technology and value-added solutions group that supports electronic payments acceptance in a multichannel environment including point-of-sale (POS), e-commerce and mobile devices, today announces that Aptito will begin processing cryptocurrency payments for its merchants starting July 1, 2019.
Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.
Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.
With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.
Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.
“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”
Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.
Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:
- Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
- Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
- Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
- Payonline – A fully integrated, processor agnostic electronic commerce platform.
Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.
“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”
Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.
Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.
From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.
Net Element (NETE), closed Thursday's trading session at $4.26, up 6.50%, on 525,158 volume with 2,417 trades. The average volume for the last 3 months is 524,481 and the stock's 52-week low/high is $3.75/$10.60.
- Net Element's Aptito Launches Cryptocurrency Payment Acceptance
- Net Element Inc. (NASDAQ: NETE) Launches Artificial Intelligence-Based Underwriting Solution
- 420 with CNW – Rhode Island Invites Blockchain Tech to Help Track Medical Marijuana
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Through a partnership agreement with TapRoot Holdings, California-based Plus Products (CSE: PLUS) (OTCQB: PLPRF) has expanded its market reach to include Nevada. To view the full article, visit: http://nnw.fm/D1aG2.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Thursday's trading session at $2.948, up 4.68%, on 178,254 volume with 271 trades. The average volume for the last 3 months is 74,720 and the stock's 52-week low/high is $2.549/$6.01.
- NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Extends Market Reach Beyond California
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Offers Secured Loan for Option to Buy Cannabis Oil Manufacturer
- Booming Supply and Demand Conditions Fueling Growing Number of Acquisitions in Cannabis Markets
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce its expansion into the global organic hemp CBD market with the launch of its Global Strategic Hemp Division. This new division will leverage TGOD's solid expertise in the European hemp CBD market to fuel growth and accelerate the development and commercialization of new products across its network of international partners. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. On Friday last week (June 14), Gov. Greg Abbott signed a bill that is focused on increasing the number of qualifying conditions for which patients can be licensed to use medical marijuana in the state. Additionally, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $2.56183, up 3.13%, on 431,914 volume with 634 trades. The average volume for the last 3 months is 821,787 and the stock's 52-week low/high is $1.61/$7.89.
- The Green Organic Dutchman Launches Global Strategic Hemp Division
- 420 with CNW – Texas Governor Signs Bill to Expand Medical Marijuana Program
- Venture Breakfast Bits, by 24/7 Market News
Green Hygienics Holdings Inc. (GRYN)
Full-scope, science-driven, premium cannabis cultivation and branding enterprise Green Hygienics Holdings (OTCQB: GRYN) today announced the appointment of four experienced professionals to its management team. To view the full press release, visit: http://nnw.fm/b7lKP.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.
The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.
Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.
Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.
Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.
The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.
Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.
Green Hygienics Holdings Inc. (GRYN), closed Thursday's trading session at $1.6045, up 6.97%, on 16,030 volume with 22 trades. The average volume for the last 3 months is 19,765 and the stock's 52-week low/high is $0.1001/$1.81.
- NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Adds Strategic Appointments to Management Team
- Green Hygienics Holdings Inc. Appoints New Management and Advisory Board to Lead Key Business Strategies
- Green Hygienics Holdings Inc. Registered to Cultivate Industrial Hemp in San Diego County, California
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce that it has successfully completed the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc. at its wholly-owned Toronto Herbal Remedies Inc. (“THR”) licensed facility.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed Thursday's trading session at $0.548, up 3.533%, on 202,153 volume with 127 trades. The average volume for the last 3 months is 809,639 and the stock's 52-week low/high is $0.189/$1.875.
- Sproutly Announces First Run of Proprietary APP Extraction Process
- Sproutly Announces First Commercial Sale of Cannabis Flower
- Sproutly Canada Inc.’s (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Proprietary Water-Soluble CBD Formula to be Delivered in Consumable Brands
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood, Inc. (OTCQB: NGTF), the nationally expanding ice cream company solving America’s $50 billion-dollar nighttime snacking problem, today announced sleep-friendly, plant-based Nightfood flavors will be presented to major supermarket chains during the 2019 summer/fall category review periods.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Thursday's trading session at $0.391, up 2.89%, on 157,136 volume with 73 trades. The average volume for the last 3 months is 232,050 and the stock's 52-week low/high is $0.16/$0.92.
- Nightfood Ice Cream Continues Rapid Expansion, Adding Plant-Based Sleep-Friendly Ice Cream to Award-Winning Product Line
- Nightfood Lands Another Top-50 Supermarket Chain; Placing Nightfood Ice Cream This Summer in All 250+ Stores
- Nightfood National Supermarket Rollout Supported by Moms Meet, Introducing Nightfood to Almost Two Million Moms Across the Country
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
Premium cannabis company VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has made a $1.25 million strategic investment in Friendly Stranger Holdings Corp., a longstanding retail champion of cannabis culture. To view the full press release, visit http://nnw.fm/n9WJq.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed Thursday's trading session at $0.3793, up 0.56%, on 175,048 volume with 123 trades. The average volume for the last 3 months is 227,017 and the stock's 52-week low/high is $0.37/$1.53.
- NetworkNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Highlights $1.25M Strategic Investment in Friendly Stranger Holdings Corp.
- NetworkNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Subsidiary’s Project Moves to 2nd Phase of Health Canada Review, Approval
- 420 with CNW – New Technologies Offer Solutions to Cannabis Dosing Challenges
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that its request to change its OTC ticker symbol from “INNPF” to “NABIF” has been approved by the Financial Industry Regulatory Authority, Inc. (“FINRA”), effective as of the opening of market trading on June 20, 2019. To view the full press release, visit: http://nnw.fm/y5X2S.
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."
While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.
Criteria for investment targets are as follows:
- Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
- Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
- Identifying proven operators with good expertise to add value to a consolidation strategy
- Focused on MSOs (Multi-state Operators) with strong brand traction
- Pharma grade cultivation, extraction, dispensaries and other addressable operations
Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.
Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.
Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.
Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.
Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.
Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.
Proven Management Team
CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.
President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.
Nabis Holdings (OTC: NABIF), closed Thursday's trading session at $0.26, up 17.65%, on 87,116 volume with 42 trades. The stock's 52-week low/high is $0.221/$0.7915.
- NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Gains Approval from FINRA to Change OTC Ticker Symbol
- Nabis Expands National Footprint with California Acquisition-- CFN Media
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Develops Vertically Integrated Cannabis Portfolio, Forecasts Revenue Growth
VPR Brands, LP (VPRB)
VPR Brands LP (OTC: VPRB), an innovative technology holding company, has partnered with top international brands in an effort to rise to the top of the booming cannabis industry. The company’s assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Thursday's trading session at $0.0504, up 0.199%, on 19,726 volume with 3 trades. The average volume for the last 3 months is 74,789 and the stock's 52-week low/high is $0.026/$0.1397.
- VPR Brands LP (VPRB) Led by Seasoned Industry Professionals, Boasts Impressive Revenue Growth
- VPR Brands LP (VPRB) Releases Cannabis Voters’ Guide to 2020 Presidential Candidates
- 420 with CNW – Maine Relaxes Residency Requirements for Recreational Marijuana Companies
SinglePoint, Inc. (SING)
Innovative technology investment enterprise SinglePoint Inc. (OTCQB: SING) is celebrating the success of its bet on solar power broker Direct Solar, a company that uses the Lending Tree model of connecting loan seekers to a variety of loan providers nationwide to allow them to effectively shop for a service that most closely fits their needs. Also today, the company was highlighted in a news story covering how American Premium Water Corporation (OTC: HIPH) (“the Company”) announces that is has sent restock shipments of its popular selling LALPINA Hydro CBD water to its online distribution partner SingleSeed (www.singleseed.com ), a subsidiary of SinglePoint, Inc (OTC: SING), twice over the past two weeks.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Thursday's trading session at $0.0163, up 32.52%, on 20,457,415 volume with 427 trades. The average volume for the last 3 months is 4,186,456 and the stock's 52-week low/high is $0.009/$0.056.
- SinglePoint Inc. (SING) Updates Revenue Forecast as Solar Contracts Exceed Expectations
- American Premium Water Corp (OTC: HIPH) Announces Restock of its Popular LALPINA CBD Water on SingleSeed.com
- Direct Solar Closes $1,709,460 in Contracts in just 30 Days, Officially Launches in Two New States, Driving Profit
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (FRANKFURT: NXFE) is pleased to announce test pit results from ongoing exploration at its flagship Cyclops, nickel/cobalt development project, Indonesia. The test pits are part of a 2019 multi-faceted program aimed at confirming historical results and providing mineralized material for process testing studies.
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.
Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.
Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.
Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.
Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.
“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”
Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.
Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.
Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.
Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Thursday's trading session at $0.1049, off by 1.13%, on 2,300 volume with 4 trades. The average volume for the last 3 months is 23,483 and the stock's 52-week low/high is $0.0701/$0.323.
- Test Pit Results Confirm Near Surface High-Grade Nickel/Cobalt Mineralization
- Pacific Rim Cobalt Corp. Featured in NetworkNewsAudio Broadcast on Growth of Indonesian Nickel Market
- Step-out Drilling Confirms and Extends High-Grade Nickel-Cobalt Mineralization
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International, Inc. (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, announced all-store distribution for its Javalution™ Hemp Infused Coffee Brand. The Javalution Brand is scheduled to ship in the fourth quarter with the distribution footprint including 400 Winn Dixie stores, 96 Bi-Lo stores, 25 Fresco Y Mas stores, and 50 Harvey stores.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed Thursday's trading session at $6.03, off by 0.17%, on 138,189 volume with 1,159 trades. The average volume for the last 3 months is 95,410 and the stock's 52-week low/high is $3.1674/$16.25.
- YGYI's CLR Roaster's Javalution Hemp Infused Coffee Lands All-Store, Multi-Chain Launch into Southeastern Grocers
- Khrysos Industries, Inc., a wholly owned subsidiary of Youngevity International, Inc. (NASDAQ: YGYI), Enters Into a 5-Year Supply Contract to purchase Hemp Plant Biomass for Extraction, Processing and Production of Hemp-Derived Products
- Youngevity International, Inc (Nasdaq:YGYI) set to join Russell 3000 Index
INmune Bio Inc. (NASDAQ: INMB)
INmune Bio (NASDAQ: INMB), a diversified clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to combat disease, is currently developing drug candidates INKmune and INB03, which may be used to treat cancer, and XPro1595, which targets neuroinflammation as a cause of Alzheimer’s disease. To view the full article, visit: http://nnw.fm/M19Hy.
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Thursday's trading session at $10.00, off by 3.57%, on 9,798 volume with 80 trades. The average volume for the last 3 months is 18,806 and the stock's 52-week low/high is $0.697/$4.43.
- NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Developing Innovative Drug Candidates to Treat Cancer, Alzheimer’s Disease
- INmune Bio Inc. Featured in Exclusive NetworkNewsWire Broadcast
- NetworkNewsBreaks – Why INmune Bio Inc. (NASDAQ: INMB) Is ‘One to Watch’
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Renews Access Agreements for Port and Power & Provides Project Update
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) in Final Negotiations to Significantly Expand Cannabis Cultivation and Retail Operations
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Invests $10M in California-Based Plant Science Innovator ZeaKal
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Resignation of Non-Executive Chairman
- ChineseInvestors.com (CIIX) Projects Continued Revenue Growth for FY2020
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Surpasses $49,000 in Opening Day Sales at the Niagara Flagship Cannabis Store
- City View Green Holdings Inc. (CSE: CVGR) Anticipates Completion of Brantford Facility Build-Out
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Earth Science Tech, Inc. (ETST) 420 with CNW – Church of England Starts Investing in Marijuana
- Endonovo Therapeutics (OTCQB: ENDV) Positioned to Benefit as Wearable Medical Devices Market Projected to Reach $66.8 Billion by 2026
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Inks Exclusive Marketing Agreement with Subsidiary of Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT)
- Genprex Inc. (NASDAQ: GNPX) Advances Toward Lead Drug
- Geyser Brands Inc. (TSX.V: GYSR) Developing, Marketing Leading Cannabis Products and Brands
- Golden Developing Solutions, Inc. (DVLP) Updates Financial Performance, Signals 160% Overall Growth Across Multiple Segments
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) New Products from Cannabis Branding Experts Gaining Shopper Attention on Store Shelves
- Green Hygienics Holdings Inc. (GRYN) Appoints New Management and Advisory Board to Lead Key Business Strategies
- QualityStocksNewsBreaks – Hemptown USA Positioned as Leading Producer of CBG — Potential Next Big Thing
- INmune Bio, Inc. (NASDAQ: INMB) Featured in Exclusive NetworkNewsWire Broadcast
- IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF) Completes Acquisition of Vegas Valley Growers North
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) DehydraTECH: The Cynosure of Efficient CBD Delivery -- CFN Media
- Marijuana Company of America Inc. (MCOA) and Joint Venture Partner Global Hemp Group Announce Start of Commercial Planting at Hemp Farm
- MustGrow Biologics Corp. Building Suite of Natural Biologic Agriculture Products to Protect Global Cannabis, Fruit & Vegetable Crops
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Expands National Footprint with California Acquisition -- CFN Media
- Net Element, Inc. (NASDAQ: NETE) Launches Artificial Intelligence-Based Underwriting Solution
- Nightfood, Inc. (OTCQB: NGTF) Lands Another Top-50 Supermarket Chain; Placing Nightfood Ice Cream This Summer in All 250+ Stores
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) 420 with CNW – Poll Shows Americans want CBD as an OTC Drug
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Featured in NetworkNewsAudio Broadcast on Growth of Indonesian Nickel Market
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Releases Virtual Tour of Asphalt Ridge Oil Sands Processing Facility
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) 420 with CNW – Poll Shows Americans want CBD as an OTC Drug
- Pressure BioSciences Inc. (PBIO) Ultra High Pressure HUB Platform Highly Effective in Studies to Develop Improved Methods for Food Safety
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Assay Results Suggest Further Tonnage at Irgon Property
- Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) Notes from the Floor: Lift Cannabis Business Conference Toronto
- Sharing Services Global Corporation (SHRG) Empowers Elepreneurs to Achieve Wellness in Both Mind and Body
- SinglePoint, Inc. (SING) Direct Solar Closes $1,709,460 in Contracts in just 30 Days, Officially Launches in Two New States, Driving Profit
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Advancing Unique Commercial Cellular Device for Public Safety and Commercial Fleet Vehicles
- Spectrum Global Solutions, Inc. (SGSI) Issues Statement About Recent Stock Trading Activity – Notice to the Public to Rely on Information only Provided by the Company
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces First Commercial Sale of Cannabis Flower
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Announces Positive Preliminary Economic Assessment and Upgrading of Mineral Resource at Its Southern Arkansas Lithium Brine Project
- Sugarmade, Inc. (SGMD) Entering Hemp CBD Extraction Equipment Market with Chinese Technological Backup
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Well-Positioned for Health Canada's Final Regulations for New Cannabis Products
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Set to Flourish with Expanding Indoor Cannabis Production
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Missouri Puts Final Touches to Medical Marijuana Rules
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Featured in CannabisNewsWire Publication on Cannabis Industry’s Steady Growth in Midst of Change
- Trxade Group Inc. (TRXD) Subsidiary Secures LegitScript Certification
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Subsidiary’s Project Moves to 2nd Phase of Health Canada Review, Approval
- VPR Brands, LP (VPRB) Releases Cannabis Voters’ Guide to 2020 Presidential Candidates
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Exclusive Interview with Wildflower Brands CEO: Health and Wellness Cannabis Products-- CFN Media
- Youngevity International, Inc. (NASDAQ: YGYI) Khrysos Industries, Inc., a wholly owned subsidiary of Youngevity International, Enters Into a 5-Year Supply Contract to purchase Hemp Plant Biomass for Extraction, Processing and Production of Hemp-Derived Products
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.